Impurity Analysis of Poly dT Oligonucleotides
Bonded Phase: OLIGO C18
Market Segment: Biopharmaceuticals
Particle Size: 2.7 µm
Pore Size: 120 Å
Product Segment: BIOCLASS
Separation Mode: Reversed Phase
Download FileBonded Phase: OLIGO C18
Market Segment: Biopharmaceuticals
Particle Size: 2.7 µm
Pore Size: 120 Å
Product Segment: BIOCLASS
Separation Mode: Reversed Phase
Download File